未登录

D

Diego A. Pedroza

baylor college of medicine

H指数:10

被引数:445

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Anti-CSF-1R therapy with combined immuno-chemotherapy coordinate an adaptive immune response to eliminate macrophage enriched triple negative breast cancers

抗-CSF-1R疗法与免疫化疗联合可协调适应性免疫应答，以消除巨噬细胞富集的三阴性乳腺癌

Nature Communications

IF15.7

2026-01-030

OA

CREB-binding protein/P300 bromodomain inhibition reduces neutrophil accumulation and activates antitumor immunity in triple-negative breast cancer

IF6.1

2024-09-170

OA

2-methoxyestradiol inhibits the malignant behavior of triple negative breast cancer cells by altering their miRNome

FRONTIERS IN ONCOLOGY

IF3.3

2024-09-120

OAAI

Leveraging preclinical models of metastatic breast cancer

利用转移性乳腺癌的临床前模型

BIOCHIMICA ET BIOPHYSICA ACTA-REVIEWS ON CANCER

IF8.3

2024-09-010

PRE

Leveraging preclinical models of triple negative breast cancer for translational research

CANCER RESEARCH

IF16.6

2024-02-010

PRE

CSF-1R antibody targeting therapy with combined metronomic chemotherapy and immune checkpoint blockade enhance a B and T cell response to attenuate metastatic triple negative breast cancer

CANCER RESEARCH

IF16.6

2024-02-010

PRE

Targeting eIF4A triggers an interferon response to synergize with chemotherapy and suppress triple-negative breast cancer

靶向eIF4A引发干扰素反应，与化疗协同抑制三阴性乳腺癌

JOURNAL OF CLINICAL INVESTIGATION

IF13.6

2023-12-158

OAAI

Tumor concentration of metformin is a determinant factor of its regulation of fatty acid β-oxidation and c-Src pathway in triple-negative breast cancer

CANCER RESEARCH

IF16.6

2023-04-040

PRE

CSF-1R antibody targeting therapy with combined metronomic chemotherapy enhances a B and T cell response for the treatment of metastatic triple negative breast cancer

CANCER RESEARCH

IF16.6

2023-03-010

PRE

miRNome and Functional Network Analysis of PGRMC1 Regulated miRNA Target Genes Identify Pathways and Biological Functions Associated With Triple Negative Breast Cancer

FRONTIERS IN ONCOLOGY

IF3.3

2021-07-194

OAAI

Crosstalk between progesterone receptor membrane component 1 and estrogen receptor α promotes breast cancer cell proliferation

LABORATORY INVESTIGATION

IF4.2

2021-06-0129

OAAI

Hepatocyte nuclear factor 1 alpha influences pancreatic cancer growth and metastasis

SCIENTIFIC REPORTS

IF3.9

2020-11-196

OAAI

Progesterone receptor membrane component 1 promotes the growth of breast cancers by altering the phosphoproteome and augmenting EGFR/PI3K/AKT signalling

BRITISH JOURNAL OF CANCER

IF6.8

2020-07-2446

OAAI

Growth hormone and prolactin influences mammary epithelial and stromal interactions in early parity induced protection against breast cancer

CANCER RESEARCH

IF16.6

2020-02-150

PRE

Progesterone receptor membrane component 1 controls cellular proliferation and plays a key role in the molecular circuitry of both ER positive and triple negative breast cancers

CANCER RESEARCH

IF16.6

2020-02-150

PRE

Progesterone receptor membrane component 1 controls cellular proliferation and plays a key role in the molecular circuitry of both ER positive and triple negative breast cancers

CANCER RESEARCH

IF16.6

2019-07-010

PRE

Pregnancy inhibits mammary carcinogenesis by altering the mammary epithelial and stromal interactions

CANCER RESEARCH

IF16.6

2019-07-010

PRE

Pregnancy inhibits mammary carcinogenesis by persistently altering the hypothalamic-pituitary axis

CANCER RESEARCH

IF16.6

2019-02-150

PRE

FOXC1 plays a crucial role in the growth of pancreatic cancer

IF6.4

2018-07-0625

OAAI

miR-424-cdc42, key signaling axis in hyperglycemic regulation of stemness in triple negative breast cancer

CANCER RESEARCH

IF16.6

2017-07-010

PRE